Nanite is a next-generation non-viral gene delivery company developing a new class of programmable polymer nanoparticles for a range of modalities and indications. The company's AI-driven platform, SAYER™, combines cutting-edge high-throughput experimental and computational methods to design fit-for-purpose delivery vehicles delivering a broad range of genetic cargoes with tissue specificity.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/15/23 | $6,000,000 | Seed |
Arkitekt Ventures Zetta Venture Partners  | undisclosed |
| 03/15/23 | $2,000,000 |
Cystic Fibrosis Foundation | undisclosed |
